WallStSmart

DocGo Inc (DCGO)vsHCA Holdings Inc (HCA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

HCA Holdings Inc generates 23364% more annual revenue ($75.60B vs $322.20M). HCA leads profitability with a 9.0% profit margin vs -56.6%. HCA earns a higher WallStSmart Score of 69/100 (B-).

DCGO

Hold

36

out of 100

Grade: F

Growth: 3.3Profit: 2.0Value: 5.0Quality: 7.0
Piotroski: 3/9Altman Z: 1.88

HCA

Strong Buy

69

out of 100

Grade: B-

Growth: 7.3Profit: 8.0Value: 10.0Quality: 6.0
Piotroski: 5/9Altman Z: 1.71
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for DCGO.

HCAUndervalued (+59.9%)

Margin of Safety

+59.9%

Fair Value

$1326.31

Current Price

$484.02

$842.29 discount

UndervaluedFair: $1326.31Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DCGO2 strengths · Avg: 9.5/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.119/10

Conservative balance sheet, low leverage

HCA5 strengths · Avg: 9.0/10
Return on EquityProfitability
136.3%10/10

Every $100 of equity generates 136 in profit

Debt/EquityHealth
-8.3310/10

Conservative balance sheet, low leverage

Market CapQuality
$108.62B9/10

Large-cap with strong market position

P/E RatioValuation
17.1x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
44.5%8/10

Earnings expanding 44.5% YoY

Areas to Watch

DCGO4 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.884/10

Grey zone — moderate risk

Market CapQuality
$66.57M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-89.0%2/10

ROE of -89.0% — below average capital efficiency

HCA1 concerns · Avg: 4.0/10
Altman Z-ScoreHealth
1.714/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : DCGO

The strongest argument for DCGO centers on Price/Book, Debt/Equity.

Bull Case : HCA

The strongest argument for HCA centers on Return on Equity, Debt/Equity, Market Cap. PEG of 1.35 suggests the stock is reasonably priced for its growth.

Bear Case : DCGO

The primary concerns for DCGO are Altman Z-Score, Market Cap, Piotroski F-Score.

Bear Case : HCA

The primary concerns for HCA are Altman Z-Score.

Key Dynamics to Monitor

DCGO profiles as a turnaround stock while HCA is a value play — different risk/reward profiles.

HCA carries more volatility with a beta of 1.34 — expect wider price swings.

HCA is growing revenue faster at 6.7% — sustainability is the question.

HCA generates stronger free cash flow (870M), providing more financial flexibility.

Bottom Line

HCA scores higher overall (69/100 vs 36/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

DocGo Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

DocGo Inc. is an innovative mobile healthcare service provider revolutionizing patient access through its advanced logistics and telehealth platform. Specializing in urgent care, diagnostic testing, and health screenings, the company enhances patient experiences while streamlining healthcare delivery across diverse environments. With strong technological integration and a commitment to expanding quality healthcare access, DocGo is well-positioned for substantial growth in the rapidly evolving healthtech sector, making it an attractive investment opportunity for institutional investors.

Visit Website →

HCA Holdings Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

HCA Healthcare is an American for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owns and operates 186 hospitals and approximately 2,000 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 21 states and the United Kingdom.

Visit Website →

Want to dig deeper into these stocks?